Replimune Group, Inc. (REPL)
8.93
+0.48
(+5.68%)
USD |
NASDAQ |
Jan 07, 16:00
8.93
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Price: 8.93 for Jan. 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Rapt Therapeutics, Inc. | 32.39 |
| Olema Pharmaceuticals, Inc. | 27.05 |
| CorMedix, Inc. | 11.18 |
| Verastem, Inc. | 7.65 |
| Anavex Life Sciences Corp. | 4.09 |
Price Related Metrics
| PEG Ratio | -0.1570 |
| Price to Book Value | 2.660 |
| Earnings Yield | -40.40% |
| Market Cap | 700.50M |
| PEGY Ratio | -0.1570 |